Raffles Medical's (SGX:BSL) attributable profit rose 4.3% in the second half of 2024 to SG$31.6 million from SG$30.3 million a year earlier, according to a filing with the Singapore Exchange on Monday.
Earnings per share climbed to SG$0.017 from SG$0.0162 in the comparable period.
Revenue was up 15% year over year to SG$385.9 million from SG$336.2 million, mainly due to improved performance from the hospital services division.
The group declared a final dividend of SG$0.025 per share.
Shares of the medical services company were up over 6% in recent trading.